ArticleFrontiers in psychiatry2024

Baseline monocyte count predicts symptom improvement during intravenous ketamine therapy in treatment-resistant depression: a single-arm open-label observational study.

Bruno Pedraz-Petrozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.